Axinn Serving as Patent Counsel for ADHD and Pain Relief Medications
May 1, 2007
Axinn represented Actavis Group in connection with its launch of multiple ADHD and pain relief medications. This representation included ongoing advice and counseling and current defense of patent litigation against generic versions of Ritalin LA®, Adderall XR® and Oxycontin.®
To subscribe to our publications, click here.
Featured Insights
Featured Insights
Informa 34th Annual Advanced EU Brussels Conference
Speaking Engagement
Antitrust
Kisaco Research Pharma and Biotech Patent Litigation Summit 2025
Speaking Engagement
Intellectual Property
GCR Live: Women in Antitrust 2025
Speaking Engagement
Antitrust
Global Legal Group Global Class Actions Symposium 2025
Speaking Engagement
Litigation & Trials
ITCTLA Mock Hearing Program 2025
Speaking Engagement
Intellectual Property
ALM General Counsel Conference East 2025
Speaking Engagement
Antitrust
Axinn Recognized in Thirteen Categories of 2026 “Best Law Firms” Report
Awards & Recognitions
Antitrust
Mastering Multi-Jurisdictional Mergers: Strategies for Navigating Complex Global Antitrust Reviews
Byline Articles
Antitrust
The Government Shutdown’s Impact on Antitrust
Axinn Viewpoints
Antitrust
NAPABA Convention 2025
Sponsorship
Antitrust

